Royal Bank Of Canada Kiniksa Pharmaceuticals, Ltd. Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 05, 2024	BUY	$17.63 - $21.74 $32,210 - $39,718	1,827 New	1,827 $36,000
Q1 2024 May 15, 2024	SELL	$17.63 - $21.74 $172,086 - $212,204	-9,761 Reduced 84.23%	1,827 $36,000
Q4 2023 Feb 14, 2024	BUY	$14.37 - $19.07 $65,167 - $86,482	4,535 Added 64.3%	11,588 $203,000
Q3 2023 Nov 14, 2023	BUY	$13.62 - $20.2 $48,078 - $71,306	3,530 Added 100.2%	7,053 $122,000
Q2 2023 Aug 14, 2023	BUY	$10.44 - $16.48 $11,275 - $17,798	1,080 Added 44.21%	3,523 $49,000
Q1 2023 May 15, 2023	SELL	$10.7 - $15.79 $24,214 - $35,732	-2,263 Reduced 48.09%	2,443 $26,000
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $46,502 - $69,427	4,072 Added 642.27%	4,706 $70,000
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $2,030 - $2,789	208 Added 48.83%	634 $8,000
Q2 2022 Aug 15, 2022	SELL	$7.6 - $11.41 $12,274 - $18,427	-1,615 Reduced 79.13%	426 $4,000
Q1 2022 May 16, 2022	SELL	$9.3 - $12.37 $42,612 - $56,679	-4,582 Reduced 69.18%	2,041 $20,000
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $38,162 - $55,645	3,673 Added 124.51%	6,623 $78,000
Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $8,018 - $11,425	704 Added 31.34%	2,950 $34,000
Q2 2021 Aug 16, 2021	BUY	$13.22 - $19.09 $29,692 - $42,876	2,246 New	2,246 $31,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.